InSphero raises €19.0M Series C round
8 July 2015· Schlieren, Switzerland· biotechnology, drug_discovery, 3d_cell_culture, in_vitro_testing, b2b, software_hardware
To rapidly expand its global footprint, broaden its portfolio of novel 3D microtissues and contract research services, and develop new products and applications.
Investors
LeadHP WILD HOLDING AG
About InSphero
Stage
Series D
Headquarters
Schlieren, Switzerland
Founded
2009
Team Size
51–200
Sectors
biotechnologydrug_discovery3d_cell_culturein_vitro_testingb2bsoftware_hardware
Source: https://insphero.com/news/insphero-ag-secures-chf-20-million-series-c-financing/